Indrayani Biotech
INDRAYANIBIOTECHLTD NSE
Indrayani Biotech
FMCGNSE: INDRAYANIBIOTECHLTD BSE: 526445 Agricultural Products
Key Fundamentals
MicrocapAgricultural ProductsFMCGMarket Cap
₹78.42 Cr
Volatility
Moderate
P/E Ratio
34.8
EBITDA
₹9.63 Cr
Return on Equity
-6.11%
Debt to Equity
1.75
Book Value
₹15.59
EPS
₹1.4
52W High
₹18.05
52W Low
₹6.69
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Stock is trading at 1.10 times its book value
Weaknesses
7- Company has low interest coverage ratio.
- Promoter holding is low: 32.9%
- Company has a low return on equity of 1.21% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.4.57 Cr.
- Company has high debtors of 155 days.
- Promoter holding has decreased over last 3 years: -12.0%
Growth Rate
Revenue Growth
3.32% higher than
3Y
Net Income Growth
-104% lower than
3Y
Cash Flow Change
77.79% higher than
3Y
ROE
-145% lower than
3Y
ROCE
-74.37% higher than
3Y
EBITDA Margin (Avg.)
-3.98% higher than
3Y
Quarterly Results
| Particulars | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 49.25 | 42.31 | 40.44 | 39.09 | 44.38 | 31.53 | 30.81 | 17.32 | 50.57 | 29.1 | 35.95 | 35.01 | 37.76 |
| Expenses | 46.07 | 39.77 | 33.15 | 35.64 | 34.21 | 25.55 | 25.7 | 14.4 | 56.31 | 26.92 | 33.5 | 32.22 | 35.54 |
| Operating Profit | 3.18 | 2.54 | 7.29 | 3.45 | 10.17 | 5.98 | 5.11 | 2.92 | -5.74 | 2.18 | 2.45 | 2.79 | 2.22 |
| OPM % | 6.46% | 6% | 18.03% | 8.83% | 22.92% | 18.97% | 16.59% | 16.86% | -11.35% | 7.49% | 6.82% | 7.97% | 5.88% |
| Other Income | 2.05 | 0.01 | 0.09 | 0.08 | 1.03 | 0.04 | 0.3 | 0 | 2.78 | 1.06 | 1.8 | 0.83 | 0.88 |
| Interest | 2.23 | 2.03 | 0.93 | 1.41 | 5.51 | 0.83 | 1.42 | 1.03 | 7.07 | 2.17 | 1.89 | 2.47 | 3.08 |
| Depreciation | 1.15 | 0.9 | 0.91 | 1.03 | 0.96 | 4.25 | 2.79 | 1.46 | -1.72 | 0.86 | 1.3 | 1.01 | 1.13 |
| PBT | 1.85 | -0.38 | 5.54 | 1.09 | 4.73 | 0.94 | 1.2 | 0.43 | -8.31 | 0.21 | 1.06 | 0.14 | -1.11 |
| Tax % | 21.62% | 15.79% | 0% | 0% | 0% | 9.57% | -1.67% | 18.6% | 2.53% | 23.81% | 14.15% | 21.43% | -187.39% |
| Net Profit | 1.44 | -0.45 | 5.54 | 1.08 | 4.73 | 0.85 | 1.22 | 0.35 | -8.53 | 0.16 | 0.91 | 0.12 | 0.98 |
| EPS in Rs | 0.18 | -0.08 | 0.94 | 0.13 | 0.5 | 0.11 | 0.16 | 0.03 | -1.09 | 0.02 | 0.05 | 0.02 | 0.13 |
Profit & Loss
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 39 | 58 | 50 | 21 | 61 | 163 | 165 | 130 | 138 |
| Expenses | 0 | 39 | 57 | 47 | 26 | 54 | 145 | 142 | 124 | 128 |
| Operating Profit | 0 | 1 | 1 | 3 | -5 | 7 | 17 | 24 | 6 | 10 |
| OPM % | -105% | 1.9% | 0.9% | 6% | -24% | 11% | 11% | 14% | 4.9% | 7% |
| Other Income | 0 | 0 | 0 | 0 | -4 | 0 | 4 | 1 | 3 | 5 |
| Interest | 0 | 0 | 0 | 1 | 2 | 2 | 6 | 10 | 12 | 10 |
| Depreciation | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 4 | 3 | 4 |
| PBT | 0 | 0 | 0 | 1 | -11 | 4 | 12 | 11 | -6 | 0 |
| Tax % | 0% | 150% | 300% | 0% | 0% | 0% | 3% | 5% | 6% | -620% |
| Net Profit | 0 | 0 | 0 | 1 | -11 | 4 | 12 | 10 | -6 | 2 |
| EPS in Rs | — | -0.08 | -0.1 | 1.31 | -1.91 | 0.76 | 1.49 | 0.81 | -0.78 | 0.28 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 4 | 4 | 4 | 34 | 34 | 34 | 46 | 46 | 46 |
| Reserves | -6 | 0 | 0 | 27 | -15 | -10 | 12 | 22 | 27 | 27 |
| Borrowings | 0 | 0 | 0 | 14 | 16 | 19 | 79 | 113 | 137 | 128 |
| Other Liabilities | 1 | 6 | 9 | 7 | 5 | 8 | 31 | 54 | 58 | 52 |
| Total Liabilities | 1 | 10 | 12 | 51 | 40 | 51 | 156 | 234 | 268 | 253 |
| Fixed Assets | 1 | 6 | 6 | 17 | 15 | 17 | 57 | 62 | 58 | 60 |
| CWIP | 0 | 0 | 0 | 14 | 14 | 13 | 14 | 20 | 26 | 27 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 4 | 7 | 21 | 11 | 22 | 85 | 151 | 184 | 166 |
| Total Assets | 1 | 10 | 12 | 51 | 40 | 51 | 156 | 234 | 268 | 253 |
Cash Flow
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating | — | 1 | 2 | 6 | 0 | 4 | 16 | -30 | -7 | 32 |
| Investing | — | -3 | 0 | -4 | -1 | -1 | -47 | -16 | 25 | -13 |
| Financing | — | 2 | -1 | -1 | 0 | -3 | 33 | 44 | -18 | -15 |
| Net Cash Flow | — | 0 | 1 | 1 | -1 | 1 | 2 | -2 | 0 | 4 |
| Free Cash Flow | — | -2 | 2 | 2 | 0 | 3 | -25 | -47 | -8 | 23 |
| CFO/OP | — | 122 | 331 | 215 | -5 | 61 | 94 | -128 | -124 | 328 |
Ratios
| Particulars | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 26 | 26 | 52 | 84 | 84 | 67 | 87 | 165 | 155 |
| Inventory Days | 365 | — | — | 57 | 25 | 14 | 44 | 159 | 182 | 147 |
| Days Payable | 365 | — | — | 70 | 77 | 52 | 81 | 141 | 104 | 55 |
| Cash Conversion Cycle | 0 | 26 | 26 | 38 | 32 | 46 | 30 | 106 | 243 | 247 |
| Working Capital Days | -1,883 | -22 | -19 | 30 | -59 | -12 | 6 | 127 | 211 | 163 |
| ROCE % | — | 28% | 12% | — | -13% | 16% | 23% | 14% | 3% | 4% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Indrayani Biotech insights
61 extracted metrics + investor summaries across FY09–FY26.
Documents
1
General Updates
28 Apr - Rights Issue Committee approved LOF, ALOF and CAF on April 28, 2026. 28 Apr - Rights Issue Committee approved LOF, ALOF and CAF on April 28, 2026.
2
General Updates
28 Apr - Rights Issue Committee approved LOF, ALOF and CAF on April 28, 2026. 28 Apr - Rights Issue Committee approved LOF, ALOF and CAF on April 28, 2026.
3
Announcement Under Regulation 30 (LODR) - IT Demand Notice
25 Apr - Income tax department raised ₹13.90 crore demand for AY2023-24; company appealed to ITAT. 25 Apr - Income tax department raised ₹13.90 crore demand for AY2023-24; company appealed to ITAT.
4
Announcement Under Regulation 30 (LODR) - IT Demand Notice
7h - Income tax department raised ₹13.90 crore demand for AY2023-24; company appealed to ITAT. 7h - Income tax department raised ₹13.90 crore demand for AY2023-24; company appealed to ITAT.
5
Intimation Of ISIN For Rights Entitlements Of Indrayani Biotech Limited
21 Apr - Intimation of RE ISIN INE007C20013 for partly paid-up rights entitlement. 21 Apr - Intimation of RE ISIN INE007C20013 for partly paid-up rights entitlement.
Frequently Asked Questions about Indrayani Biotech
What does Indrayani Biotech Ltd do?
Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]
Where is Indrayani Biotech Ltd (526445) listed?
Indrayani Biotech Ltd trades as INDRAYANIBIOTECHLTD on the NSE and under code 526445 on the BSE.
Which sector does Indrayani Biotech Ltd belong to?
Indrayani Biotech Ltd is classified under the FMCG sector, in the Agricultural Products industry.
What is the market capitalisation of Indrayani Biotech Ltd?
Indrayani Biotech Ltd has a market capitalisation of ₹78.42 Cr, which places it in the Small Cap band.
What is the PE ratio of Indrayani Biotech Ltd?
Indrayani Biotech Ltd trades at a PE ratio of 34.80, on earnings per share of ₹1.4, against a book value of ₹15.59 per share.
What is the 52-week high and low of Indrayani Biotech Ltd?
Over the last 52 weeks Indrayani Biotech Ltd has traded between ₹6.69 and ₹18.05.
What is the Return on Equity (ROE) of Indrayani Biotech Ltd?
Indrayani Biotech Ltd reported a return on equity of -6.11%. Its debt-to-equity ratio is 1.75.
Company Information
Incorporated in 1992, Indrayani Biotech Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526445.md for Indrayani Biotech Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.